Laboratory work (IMAGE) University of Eastern Finland Caption In this study, promoter capture Hi-C, ChIP-Seq, STARR-Seq and CRISPR technologies were used to study the action of coronary artery disease risk variants in hepatocyte cells of the liver. Credit UEF/Raija Törrönen. Usage Restrictions Please mention the photo credit License Licensed content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.